Zithromax and Ranexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zithromax and Ranexa. Common interactions include gingival pain among females and crohn's disease among males.

The phase IV clinical study analyzes what interactions people who take Zithromax and Ranexa have. It is created by eHealthMe based on reports of 47 people who take Zithromax and Ranexa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 07, 2022

47 people who take Zithromax and Ranexa together, and have interactions are studied.

What is Zithromax?

Zithromax has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 33,929 Zithromax users for its effectiveness, alternative drugs and more.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,089 Ranexa users for its effectiveness, alternative drugs and more.

Number of Zithromax and Ranexa reports submitted per year:

Common Zithromax and Ranexa drug interactions by gender *:

female:

Gingival pain
Haematocrit decreased
Haemoptysis
Haemothorax
Hepatic cirrhosis
Immunodeficiency
Insomnia
Kidney infection
Liver disorder
Melaena

male:

Crohn's disease
Drug hypersensitivity
Benign prostatic hyperplasia
Cerebrovascular accident
Chronic obstructive pulmonary disease
Coronary artery disease
Essential hypertension
Hyperlipidaemia
Lung neoplasm malignant
Peripheral vascular disorder

Common Zithromax and Ranexa drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Hyperparathyroidism secondary
Nephrogenic anaemia
Renal failure

40-49:

Chronic kidney disease
Gastrooesophageal reflux disease

50-59:

Vomiting
Chronic obstructive pulmonary disease
Electrocardiogram qt prolonged
Adverse drug reaction
Cataract
Diarrhoea
Drug hypersensitivity
Nausea
Parkinson's disease
Rash

60+:

Dyspnoea
Fatigue
Crohn's disease
Haemoptysis
Vomiting
Chills
Diarrhoea
Nausea
Pyrexia
Abdominal pain

Common conditions people have *:

High Blood Cholesterol: 5 people, 10.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 10.64%
Stable Angina (a constant chest pain): 4 people, 8.51%
Diabetes: 4 people, 8.51%
Cardiac Disorder: 4 people, 8.51%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 8.51%
Pain: 3 people, 6.38%
Multiple Myeloma (cancer of the plasma cells): 3 people, 6.38%
High Blood Pressure: 3 people, 6.38%
Back Pain: 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Zithromax and Ranexa?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Zithromax (33,929 reports)
Ranexa (11,089 reports)